entertainment -WSS

entertainment

author：focus 2025-09-05 09:17:29 - browse：86

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

WSS

'Investigate these claims': UFO transparency at center of House hearing

3 medical device trends to watch in 2024

Antibiotic resistance and the global rise in human conflict

Antibiotic resistance and the global rise in human conflict

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Roche’s Alnylam deal shows drug firms interested in heart drugs

knowledge

entertainment

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Affirmative action in medical school literally saved lives

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Psychedelics group wrestles with new pharma identity

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Chronically ill young patients struggle to find fertility info

Hollywood unions extend contract negotiations for actors

In the gardens at Boston Children's Hospital, families find sanctuary

explore

CDC Director Mandy Cohen on transparency, trust, and health

Ahead of JPM, here's who's profiting most in health care

Dems pitch expanding Medicare power to negotiate drug prices

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

AdventHealth escalates lawsuit against insurance vendor Multiplan

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

explore

hotspot

knowledge

hotspot